Development of a Live-Cell Imaging Assay to Elucidate Spatiotemporal Dynamics of Extracellular Vesicle Fusion with Target Cells

Journal Article (2026)
Author(s)

Jasper van den Ende (Universiteit Utrecht)

Kyra A.Y. Defourny (Universiteit Utrecht)

Huib H. Rabouw ( University Medical Centre Utrecht)

Marvin E. Tanenbaum (Kavli institute of nanoscience Delft, TU Delft - BN/Marvin Tanenbaum Lab, University Medical Centre Utrecht)

Richard W. Wubbolts (Universiteit Utrecht)

Esther N.M. Nolte-‘t Hoen (Universiteit Utrecht)

DOI related publication
https://doi.org/10.1002/jev2.70228 Final published version
More Info
expand_more
Publication Year
2026
Language
English
Journal title
Journal of Extracellular Vesicles
Issue number
3
Volume number
15
Article number
e70228
Downloads counter
10
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Cells communicate via extracellular vesicles (EVs) containing functional RNAs, proteins, and lipids. Knowledge on the fate of internalized EVs, especially their capacity to fuse with target cell membranes and deliver luminal cargo, is limited. Currently available EV-cargo delivery assays are indirect and thus unlikely to uncover molecular players and conditions that specifically control the EV-fusion step. Here, we present a novel live-cell imaging assay for detection of EV-binding, -uptake, and -fusion in time and space. We employed the SunTag system for exceptional signal amplification. EV-donor cells were engineered to tag the luminal EV-membrane with a fluorescent label coupled to SunTag peptides. Recipient cells express fluorescent single-chain anti-SunTag antibody (STAb), which binds EV-enclosed SunTag upon its cytosolic exposure. Using SunTagged EVs carrying fusogen VSV-G, we visualize the EV-fusion process, quantify fusion kinetics and efficiency, and determine subcellular localization of fusion events. We term this methodology the Extracellular Vesicle Fusion Spatiotemporal Imaging Method (EV-FUSIM). In the future, this technology can support the identification of fusogenic EV-subsets, as well as molecular players and drugs that modulate EV-fusion, without confounding effects of post-fusion processes. This will extend knowledge on EV-biology and can aid in the engineering of EVs that efficiently deliver intraluminal therapeutic payloads.